Emotional Burden of Healthcare Professionals and Covid Infection 19

Emotionnal Distress; COVID-19 Clinical Trial

— Emocovid  

Official title:

Emotional Burden of Healthcare Professionals and the Epidemic Related to Covid Infection 19 -

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04350099
• Other study ID #: 87RI20_0015/Emocovid
• Status: Recruiting
• Start date: April 15, 2020
• Est. completion date: June 15, 2021

Study information

• Verified date: April 2020
• Source: University Hospital, Limoges
• Contact: Anne-Laure FAUCHAIS, MD
• Phone: 0555051640
• Email: alfauchais[@]orange.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

COVID-19 ( known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) has a highly polymorphic clinical presentation, ranging from pauci-symptomatic infection to severe, potentially complicated forms with acute respiratory distress syndrome or multisystemic organs failure. The picture may be initially severe, or it may progress in two stages, with worsening 7 to 10 days after the first symptoms with an overall case-fatality rate of 3 to 4%.

Its management is essentially symptomatic, as no antiviral treatment has so far demonstrated a clinical benefit in this condition.

In such a context, healthcare professionals assigned to COVID units will be faced with a heavy workload and emotional burden that could lead to psychological suffering or even burnout and its consequences.

We would therefore like to describe, using validated tools, the emotional evolution of the care workers at the Limoges University Hospital and the Esquirol University Hospital faced with this new pandemic infection. An initial and end-of-study evaluation of the caregivers will be carried out concerning their anxiety and depressive state, their personal capacity for resilience and their degree of empathy

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: June 15, 2021
• Est. primary completion date: February 15, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Health professional working in a COVID unit

• For the qualitative study: 24 participant selected at random to be interviewed

Exclusion Criteria:

• Refusal to participate

Related Conditions & MeSH terms

• Emotionnal Distress; COVID-19
• Infection

Intervention

Other:
• quetionnary
Participants will complete self-questionnaires at different times during the epidemic

Locations

Country	Name	City	State
France	CH Esquirol	Limoges
France	CHU de Limoges	Limoges
France	HCL LYON	Lyon

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Limoges

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	anxiety	Assessing the anxiety of health professionals using Anxiety Disorder Assessment (GAD-7) scale.; Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively.	7 days,
Primary	anxiety	Assessing the anxiety of health professionals using Anxiety Disorder Assessment (GAD-7) scale.; Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively.	15 days,
Primary	anxiety	Assessing the anxiety of health professionals using Anxiety Disorder Assessment (GAD-7) scale.; Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively.	1 month
Primary	anxiety	Assessing the anxiety of health professionals using Anxiety Disorder Assessment (GAD-7) scale.; Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively.	3 month